Business Context and Reporting Period
This Form 8-K Current Report was filed by Niagen Bioscience, Inc. (formerly ChromaDex Corporation) on March 17, 2025. The report details a corporate name change and corresponding ticker symbol update effective March 19, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Corporate Name: Changed from "ChromaDex Corporation" to "Niagen Bioscience, Inc."
- Effective Date: 12:01 a.m. Eastern Time on March 19, 2025.
- Ticker Symbol: Changed to "NAGE" on The Nasdaq Capital Market, effective March 19, 2025.
- CUSIP Number: Remains unchanged.
- Stock Certificates: Existing certificates with the former name remain valid; new certificates will be issued upon exchange or transfer.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors. It references a press release (Exhibit 99.1) issued on March 19, 2025, regarding the name change.
Investor Verification Checklist
- Confirm the new ticker symbol "NAGE" is active on Nasdaq starting March 19, 2025.
- Verify that existing stock certificates remain valid despite the name change.
- Review the attached Certificate of Amendment (Exhibit 3.1) and Amended Bylaws (Exhibit 3.2) for any other governance modifications.
- Check the press release (Exhibit 99.1) for strategic rationale behind the rebranding.